290 results on '"Miyamoto, Shigeki"'
Search Results
2. Analyze the SUMOylation of IKKγ/NEMO During Genotoxic Stress
3. Correction for Romero et al., “Pseudorabies Virus Infection Results in a Broad Inhibition of Host Gene Transcription”
4. A gain-of-function p53 mutant synergizes with oncogenic NRAS to promote acute myeloid leukemia in mice
5. HAPLN1 matrikine: A bone marrow homing factor linked to poor MM patient outcomes
6. Several Alphaherpesviruses Interact Similarly with the NF-κB Pathway and Suppress NF-κB-Dependent Gene Expression
7. Role of mitochondria-bound HK2 in rheumatoid arthritis fibroblast-like synoviocytes
8. Supplementary Figure from A Hyaluronan and Proteoglycan Link Protein 1 Matrikine: Role of Matrix Metalloproteinase 2 in Multiple Myeloma NF-κB Activation and Drug Resistance
9. Data from A Hyaluronan and Proteoglycan Link Protein 1 Matrikine: Role of Matrix Metalloproteinase 2 in Multiple Myeloma NF-κB Activation and Drug Resistance
10. Supplemental Tables 1 - 2, Figures 1 - 3 from Tumoricidal Effects of Macrophage-Activating Immunotherapy in a Murine Model of Relapsed/Refractory Multiple Myeloma
11. Data from A Hyaluronan and Proteoglycan Link Protein 1 Matrikine: Role of Matrix Metalloproteinase 2 in Multiple Myeloma NF-κB Activation and Drug Resistance
12. Supplementary Figure S1 from Bortezomib-Resistant Nuclear Factor-κB Activity in Multiple Myeloma Cells
13. Supplementary Figure from A Hyaluronan and Proteoglycan Link Protein 1 Matrikine: Role of Matrix Metalloproteinase 2 in Multiple Myeloma NF-κB Activation and Drug Resistance
14. Supplementary Figure S1 from Bortezomib-Resistant Nuclear Factor-κB Activity in Multiple Myeloma Cells
15. Data from Tumoricidal Effects of Macrophage-Activating Immunotherapy in a Murine Model of Relapsed/Refractory Multiple Myeloma
16. Supplemental Tables 1 - 2, Figures 1 - 3 from Tumoricidal Effects of Macrophage-Activating Immunotherapy in a Murine Model of Relapsed/Refractory Multiple Myeloma
17. Data from Bortezomib-Resistant Nuclear Factor-κB Activity in Multiple Myeloma Cells
18. Data from Tumoricidal Effects of Macrophage-Activating Immunotherapy in a Murine Model of Relapsed/Refractory Multiple Myeloma
19. Supplementary Figures 1-3 from NFKB1 Is a Direct Target of the TAL1 Oncoprotein in Human T Leukemia Cells
20. Supplementary Figures 1-3 from NFKB1 Is a Direct Target of the TAL1 Oncoprotein in Human T Leukemia Cells
21. Hippo signaling pathway and mitochondrial dysfunction in takotsubo syndrome
22. Contributors
23. Role of Autophagy in Cardiac Physiology and Pathophysiology
24. NEMO is Essential for Directing IKKα and ATM to the Sites of DNA Damage
25. Ectopic CH60 mediates HAPLN1-induced cell survival signaling in multiple myeloma
26. HAPLN1 confers multiple myeloma cell resistance to several classes of therapeutic drugs
27. The SUMO protease SENP1 promotes aggressive behaviors of high HIF2α expressing renal cell carcinoma cells
28. RHOA, a small G-protein, signals to mitophagy through regulation of PINK1 protein stability and protects cardiomyocytes against ischemia
29. Correction for Romero et al., “Pseudorabies Virus Infection Results in a Broad Inhibition of Host Gene Transcription”
30. Pseudorabies Virus Infection Results in a Broad Inhibition of Host Gene Transcription
31. RhoA signaling increases mitophagy and protects cardiomyocytes against ischemia by stabilizing PINK1 protein and recruiting Parkin to mitochondria
32. Timelapse viability assay to detect division and death of primary multiple myeloma cells in response to drug treatments with single cell resolution
33. A Hyaluronan and Proteoglycan Link Protein 1 Matrikine: Role of Matrix Metalloproteinase 2 in Multiple Myeloma NF-κB Activation and Drug Resistance
34. Regulation of Glioblastoma Stem Cell Properties and Tumor Invasion by G ⍺12 Signaling
35. Splicing and Dicing: A Deeper Dive Into CaMKIIδ and Cardiac Inflammation
36. Molecular Signaling to Preserve Mitochondrial Integrity against Ischemic Stress in the Heart: Rescue or Remove Mitochondria in Danger
37. Dissecting NF-κB Signaling Induced by Genotoxic Agents via Genetic Complementation of NEMO-Deficient 1.3E2 Cells
38. Cardiomyocyte NLRP3 Contributes to the Cardiac Inflammatory Response
39. ATPase Inhibitory Factor-1 Disrupts Mitochondrial Ca2+ Handling and Promotes Pathological Cardiac Hypertrophy through CaMKIIδ
40. ATPase Inhibitor Factor-1 Disrupts Mitochondrial Ca2+ Handling and Promotes Pathological Cardiac Hypertrophy through CaMKIIδ
41. SiglecF(HI) Marks Late‐Stage Neutrophils of the Infarcted Heart: A Single‐Cell Transcriptomic Analysis of Neutrophil Diversification
42. IκBα Nuclear Export Enables 4-1BB–Induced cRel Activation and IL-2 Production to Promote CD8 T Cell Immunity
43. Histamine-induced biphasic activation of RhoA allows for persistent RhoA signaling
44. IκBα deficiency imposes a fetal phenotype to intestinal stem cells
45. NLRP3 Inflammasome Products IL‐1beta and IL‐18 Have A Direct Effect on Cardiomyocytes
46. Cardiomyocyte‐generated Monocyte Chemoattractant Protein 1 Contributes to Cardiac Inflammation During Adverse Remodeling in Pressure Overload
47. Regulation of glioblastoma tumor growth and stem cell properties through Gα12: an upstream player in YAP signaling
48. RhoA induces mitophagy through PINK1 stabilization to confer cardioprotection
49. Versican Proteolytic Fragments (Matrikines) Regulate the Intratumoral Dendritic Cell Milieu In Vivo: Implications for in Situ Tumor Vaccination
50. Inflammation in nonischemic heart disease: initiation by cardiomyocyte CaMKII and NLRP3 inflammasome signaling
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.